TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
46 hedge funds and large institutions have $70.2M invested in Talis Biomedical Corporation Common Stock in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $119M → $70.2M (-$49M)
Holders
46
Holding in Top 10
–
Calls
$84K
Puts
$74K
Top Buyers
| 1 | +$7.83M | |
| 2 | +$877K | |
| 3 | +$780K | |
| 4 |
Two Sigma Investments
New York
|
+$392K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$249K |
Top Sellers
| 1 | -$9.69M | |
| 2 | -$6.18M | |
| 3 | -$4.88M | |
| 4 |
Morgan Stanley
New York
|
-$690K |
| 5 |
Bank of New York Mellon
New York
|
-$166K |